Intervention Review

Galantamine for vascular cognitive impairment

  1. Jacqueline Birks1,*,
  2. David Craig2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 25 JAN 2006

Assessed as up-to-date: 12 JAN 2013

DOI: 10.1002/14651858.CD004746.pub2


How to Cite

Birks J, Craig D. Galantamine for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004746. DOI: 10.1002/14651858.CD004746.pub2.

Author Information

  1. 1

    University of Oxford, Centre for Statistics in Medicine, Oxford, UK

  2. 2

    Queen's University Belfast, Department of Geriatric Medicine, Belfast, Northern Ireland, UK

*Jacqueline Birks, Centre for Statistics in Medicine, University of Oxford, Wolfson College, Linton Road, Oxford, OX2 6UD, UK. jacqueline.birks@csm.ox.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 25 JAN 2006

SEARCH

  1. Current Version

    Galantamine for vascular cognitive impairment

    Jacqueline Birks and David Craig

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD004746.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Galantamine for vascular cognitive impairment

    D Craig and J Birks

    Article first published online: 19 APR 2004 | DOI: 10.1002/14651858.CD004746